CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $823 | +100.7% | 27,681 | +21.7% | 0.00% | 0.0% |
Q2 2023 | $410 | -11.3% | 22,739 | -20.9% | 0.00% | 0.0% |
Q1 2023 | $462 | -35.5% | 28,764 | -26.5% | 0.00% | 0.0% |
Q4 2022 | $716 | -99.9% | 39,120 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $769,000 | +21.3% | 39,148 | +15.2% | 0.00% | 0.0% |
Q2 2022 | $634,000 | -8.1% | 33,992 | +8.2% | 0.00% | 0.0% |
Q1 2022 | $690,000 | -7.8% | 31,421 | +19.4% | 0.00% | 0.0% |
Q4 2021 | $748,000 | +34.8% | 26,317 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $555,000 | -6.6% | 26,387 | -16.3% | 0.00% | 0.0% |
Q2 2021 | $594,000 | +56.7% | 31,522 | +27.1% | 0.00% | – |
Q1 2021 | $379,000 | +8.3% | 24,800 | 0.0% | 0.00% | – |
Q4 2020 | $350,000 | -10.0% | 24,800 | 0.0% | 0.00% | – |
Q3 2020 | $389,000 | -10.4% | 24,800 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $434,000 | +132.1% | 24,800 | +95.3% | 0.00% | – |
Q1 2020 | $187,000 | -41.4% | 12,700 | 0.0% | 0.00% | – |
Q4 2019 | $319,000 | +67.0% | 12,700 | 0.0% | 0.00% | – |
Q3 2019 | $191,000 | -39.9% | 12,700 | 0.0% | 0.00% | – |
Q2 2019 | $318,000 | +241.9% | 12,700 | +209.8% | 0.00% | – |
Q1 2019 | $93,000 | -24.4% | 4,100 | 0.0% | 0.00% | – |
Q4 2018 | $123,000 | – | 4,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |